Copyright © 2021 Pharmascimed. All Rights Reserved.
Images
NICE approves Novartis’ Kymriah in DLBCL
- February 1, 2019
- 0
The National Institute for Health and Care Excellent (NICE) has approved Novartis' chimeric antigen receptor T-cell (CAR-T cell) therapy Kymriah for use in adults with diffuse large B-cell lymphoma (DLBCL)....
Read more
Proteus launches new digital cancer pill
- January 17, 2019
- 0
Patients in the U.S. have been given digital cancer drugs for the first time in a bid to improve outcomes and adherence. The pill combines the drug capecitabine, used for grade...
Read more